Dialysis News and Research

Latest Dialysis News and Research

Cantel Medical achieves record revenue growth in fourth quarter 2014

CANTEL MEDICAL CORP. reported net income of $10,705,000, or $0.26 per diluted share, on a 15% increase in sales to a record $131,377,000 for the fourth quarter ended July 31, 2014, inclusive of $0.02 for charges related to acquisition and CFO retirement costs.

29 Sep 2014

Cedars-Sinai scientists test ELAD bioartificial liver support system for patients with acute liver failure

Cedars-Sinai physicians and scientists are testing a novel, human cell based, bioartificial liver support system for patients with acute liver failure, often a fatal diagnosis.

23 Sep 2014

Highlights: Hawaii public hospital cuts; La. struggles with state worker health program costs; aging in Ky.

Public hospitals across Hawaii are finding ways to reduce staff and cut services because they don't have enough money to make ends meet. Executives from the Hawaii Health Systems Corp. told lawmakers Friday that even after layoffs they are facing a $30 million deficit in 2015. One hospital on Maui chose to close its adolescent psychology unit because it couldn't sustain the appropriate staffing levels to provide the services. It's also considering cuts to oncology and dialysis services if the situation doesn't improve (9/20).

23 Sep 2014

Falcon Physician certified for Meaningful Use Stage 2

Falcon Physician, a provider of electronic health record (EHR) software to nephrologists and a subsidiary of DaVita HealthCare Partners, a leading provider of kidney care and health care services, announced that it has successfully completed the rigorous requirements needed to become certified for Meaningful Use Stage 2.

22 Sep 2014

Gilead to boost price of new hepatitis c drug

Gilead Sciences says its next generation drug to combat hepatitis C, slated to launch next month, will be more expensive than $1,000-a-pill Sovaldi, in part because the new treatment will be shorter and simpler. Gilead also struck a deal with Indian generic drugmakers to sell lower-cost versions of Sovaldi in poor countries.

From Baxter International Inc. 16 Sep 2014

New iodine-based contrast material enhances CT images to safely use in most patients

According to new research performed at the Mayo Clinic, iodine-based contrast material injected intravenously to enhance computed tomography (CT) images can be safely used in most patients. The study appears online in the journal Radiology.

9 Sep 2014

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

Silvergate Pharmaceuticals, Inc., focused on the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Epaned for the treatment of symptomatic heart failure and the treatment of asymptomatic left ventricular dysfunction (to decrease the rate of development of overt heart failure and to reduce hospitalization for heart failure).

9 Sep 2014

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.

6 Sep 2014

DaVita Kidney Care hosts online Google+ Hangout on Air

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, will host an online Google+ Hangout on Air called "Kidney Diet Tips: Diabetes Edition" on Monday, Sept. 8 at 5:00 p.m. PT/8:00 p.m. ET.

4 Sep 2014

Clinical studies to treat unmet medical need post-transplantation

A class of biotechnology drugs called monoclonal antibodies is now being tested in clinical studies to treat an unmet medical need post-transplantation, called delayed graft function

3 Sep 2014

Researchers create new drug to reduce inflammation of donor organ after transplantation

To reduce the number of discards and thus make more kidneys available, researchers and medical scientists from the European consortium MABSOT have created a new drug called OPN-305 to reduce inflammation of the donor organ after transplantation.

3 Sep 2014

‘Concerning’ rise in pneumococcus risk factors

Researchers report that the incidence of Streptococcus pneumoniae infection has fallen significantly in the USA in the past decade but describe a “concerning trend” whereby the baseline health status of those with serious pneumococcal disease has worsened.

1 Sep 2014

'Good' cholesterol turns 'bad' by sugar-derived substance

Scientists at the University of Warwick have discovered that 'good' cholesterol is turned 'bad' by a sugar-derived substance.

1 Sep 2014

Jardiance (empagliflozin) tablets now available in U.S. for people with diabetes

Jardiance (empagliflozin) tablets are now available by prescription in pharmacies across the United States, including Walgreens, Rite Aid, Kroger and many other leading chain and independent retailers, according to Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company.

26 Aug 2014

Amgen’s AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints

Amgen (NASDAQ: AMGN) today announced that a second placebo-controlled Phase 3 study evaluating AMG 416 for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD), receiving hemodialysis, met its primary and all secondary endpoints.

19 Aug 2014

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Decision Resources has expanded its disease-level coverage of the Treatment Algorithms Insight Series, which examines U.S. physicians' prescribing behavior, to provide a quantitative analysis of an agent's penetration into each line of therapy.

19 Aug 2014

DaVita HealthCare Partners recognized as Metro Denver's healthiest extra-large employer

DaVita HealthCare Partners Inc., a leading provider of kidney care and health care services, today announced it has been recognized by the Denver Business Journal as Metro Denver's healthiest extra-large employer. This is the third consecutive year the publication has recognized the company's commitment to teammate health and wellness with a first place rank in the Healthiest Employer award program.

18 Aug 2014

Longer looks: Kentucky is health law poster child; how to negotiate a lower medical bill; the Ebola outbreak up close

About a year ago, on Aug. 22, a team of inspectors from the Centers for Medicare and Medicaid Services (CMS) unit of the U.S. Department of Health and Human Services arrived in Frankfort, Ky., to see if the people working out of a nondescript warehouse there were going to be able to pull off the launch of Kentucky's Obamacare health-insurance exchange.

8 Aug 2014

NxStage Medical reports record revenues for Q2 2014

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported second quarter revenue that exceeds the top end of its guidance range.

7 Aug 2014

Depressive symptoms and pain in patients on dialysis may have serious negative consequences

Depressive symptoms and pain in patients on dialysis may have serious negative consequences for patients' health and increase the need for costly medical services, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

1 Aug 2014

Dialysis News and Research

Latest Dialysis News and Research

Cantel Medical achieves record revenue growth in fourth quarter 2014

Cedars-Sinai scientists test ELAD bioartificial liver support system for patients with acute liver failure

Highlights: Hawaii public hospital cuts; La. struggles with state worker health program costs; aging in Ky.

Falcon Physician certified for Meaningful Use Stage 2

Gilead to boost price of new hepatitis c drug

New iodine-based contrast material enhances CT images to safely use in most patients

FDA approves Epaned for treatment of symptomatic and asymptomatic heart failure

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

DaVita Kidney Care hosts online Google+ Hangout on Air

Clinical studies to treat unmet medical need post-transplantation

Researchers create new drug to reduce inflammation of donor organ after transplantation

‘Concerning’ rise in pneumococcus risk factors

'Good' cholesterol turns 'bad' by sugar-derived substance

Jardiance (empagliflozin) tablets now available in U.S. for people with diabetes

Amgen’s AMG 416 Phase 3 placebo-controlled study meets primary and secondary endpoints

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

DaVita HealthCare Partners recognized as Metro Denver's healthiest extra-large employer

Longer looks: Kentucky is health law poster child; how to negotiate a lower medical bill; the Ebola outbreak up close

NxStage Medical reports record revenues for Q2 2014

Depressive symptoms and pain in patients on dialysis may have serious negative consequences

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Dialysis News and Research

Latest Dialysis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in